Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 56NIH 8NETWORK 3INDUSTRY 3OTHER_GOV 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 5Gastrointestinal 3Sarcoma 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Colorectal Neoplasms 3Colonic Neoplasms 3Rectal Neoplasms 1

Interventions

Fluorouracil 74Leucovorin 48Oxaliplatin 44Cisplatin 40Capecitabine 39Gemcitabine 37Radiotherapy 30Irinotecan 28Cetuximab 21Paclitaxel 15Bevacizumab 12Docetaxel 10Taxes 9durvalumab 8dehydroftorafur 8Surgical Procedures, Operative 8Mitomycin 8Specimen Handling 7Platinum 7Folfox protocol 7Carboplatin 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7S 1 (combination) 6Panitumumab 6Watchful Waiting 5Imatinib Mesylate 5Gene Expression Profiling 5Epirubicin 5tremelimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Celecoxib × Gastrointestinal × Clear all
NCT00085163 2015-10-20

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00087256 2013-01-07

Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

NSABP Foundation Inc

Phase 3 Terminated
18 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00064181 2012-09-24

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
86 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡